PF-Atlas › Clinical Trials › NCT04444609
PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort
Blood tests sputum, nasal lavage and brushing · Not specified
Registry ID
NCT04444609
Phase
Not specified
Status
Unknown
Drug / intervention
Blood tests sputum, nasal lavage and brushing
Sponsor
Imperial College London
Start
2020-06-18
Enrollment
161
Locations
1
About this trial
DESIGN Longitudinal prospective observational multicentre study. Primary objective: Understand the immune mechanisms driving COVID-19 disease in patients with a history of lung disease
Explore related
Medical disclaimer. This page summarizes public trial data for NCT04444609 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.